March 18 (Reuters) - Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz ...
patent lawsuit against Sandoz over potential generic entry of its Prolia and Xgeva drugs was cancelled. Amgen shares rose almost 2%. The court hearing in New Jersey was scheduled for today.